{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T07:10:45Z","timestamp":1779261045614,"version":"3.51.4"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","license":[{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100011912","name":"Washington University School of Medicine","doi-asserted-by":"crossref","award":["Mentors in Medicine"],"award-info":[{"award-number":["Mentors in Medicine"]}],"id":[{"id":"10.13039\/100011912","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Much remains unknown about the impact of initial antibiotic adequacy on mortality in community onset bacterial pneumonia (COBP). Therefore, we performed a study to determine how the adequacy of initial antibiotic therapy affects in-hospital mortality for patients with COBP.<\/jats:p>\n            <jats:p>We carried out a retrospective cohort study among the 11 BJC Healthcare community and academic hospitals in Missouri and Illinois. The electronic medical records for BJC Healthcare were queried to obtain a set of patient admissions with culture positive (respiratory or blood) COBP admitted from January 1, 2016 through December 31, 2019. Patients with COBP required an International Classification of Diseases (ICD)-10 diagnostic code for pneumonia, admission to the hospital through an emergency department, a chest radiograph with an infiltrate, an abnormal white blood cell count or temperature, an order for 1 or more new antibiotics, and a positive respiratory or blood culture. Antibiotic selection was deemed adequate if the patient had organisms susceptible to at least one of the antibiotics received according to in vitro testing using standard laboratory breakpoints.<\/jats:p>\n            <jats:p>Among 36,645 screened pneumonia admissions, 1843 met criteria for culture positive COBP. Eight hundred nineteen (44.4%) had ceftriaxone-resistant (CTX-R) organisms and 1024 had ceftriaxone-sensitive (CTX-S) organisms. The most common CTX-R pathogens were methicillin resistant <jats:italic toggle=\"yes\">Staphylococcus aureus<\/jats:italic> (46.9%), <jats:italic toggle=\"yes\">Pseudomonas<\/jats:italic> species (38.4%), and <jats:italic toggle=\"yes\">Escherichia coli<\/jats:italic> (4.5%). On the day of admission 71% of all patients were given adequate antibiotic treatment (62.2% of CTX-R and 77.9% of CTX-S). Unnecessarily broad initial treatment was administered to 57.1% of CTX-S patients. In a logistic regression model accounting for comorbidities and severity of illness, inadequate therapy on the day of admission was associated with higher in-hospital mortality (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.005). Among CTX-S patients who were adequately treated, initial use of unnecessarily broad antibiotics was associated with increased in-hospital mortality (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.003).<\/jats:p>\n            <jats:p>Ceftriaxone resistance was common in this cohort of culture positive COBP patients. Inappropriate coverage on day of admission was associated with greater likelihood of in-hospital mortality.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000029159","type":"journal-article","created":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T14:07:12Z","timestamp":1653401232000},"page":"e29159","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Ceftriaxone resistance and adequacy of initial antibiotic therapy in community onset bacterial pneumonia"],"prefix":"10.1097","volume":"101","author":[{"given":"Richard F.","family":"Van Besien","sequence":"first","affiliation":[{"name":"Department of Medicine, Washington University School of Medicine. St. Louis, MO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Hampton","sequence":"additional","affiliation":[{"name":"Center for Clinical Excellence, BJC Healthcare, St. Louis, MO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott T.","family":"Micek","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, University of Health Sciences and Pharmacy, St. Louis, MO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0671-0751","authenticated-orcid":false,"given":"Marin H.","family":"Kollef","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,5,20]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1093\/cid\/cix647","article-title":"Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality","volume":"65","author":"Ramirez","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1500245","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. adults","volume":"373","author":"Jain","year":"2015","journal-title":"N Engl J Med"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/cid\/cix549","article-title":"Evolving understanding of the causes of pneumonia in adults, with special attention to the role of pneumococcus","volume":"65","author":"Musher","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"S296","DOI":"10.1093\/cid\/cir045","article-title":"Diagnostic tests for agents of community-acquired pneumonia","volume":"52","author":"Bartlett","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.idc.2019.07.002","article-title":"Antibiotic-resistant community-acquired bacterial pneumonia","volume":"33","author":"Ho","year":"2019","journal-title":"Infect Dis Clin North Am"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00134-019-05519-y","article-title":"Challenges in severe community-acquired pneumonia: a point-of-view review","volume":"45","author":"Torres","year":"2019","journal-title":"Intensive Care Med"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/cid\/cir813","article-title":"Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department","volume":"54","author":"Shorr","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1900057","DOI":"10.1183\/13993003.00057-2019","article-title":"Broad-spectrum antibiotic use and poor outcomes in community-onset pneumonia: a cohort study","volume":"54","author":"Webb","year":"2019","journal-title":"Eur Respir J"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/MAJ.0b013e318294833f","article-title":"Patterns of initial antibiotic therapy for community-acquired pneumonia in U.S. hospitals, 2000 to 2009","volume":"347","author":"Berger","year":"2014","journal-title":"Am J Med Sci"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1097\/CCM.0000000000000330","article-title":"Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program","volume":"42","author":"Ferrer","year":"2014","journal-title":"Crit Care Med"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s13054-015-1000-z","article-title":"Adequate antibiotic therapy prior to ICU admission in patients with severe sepsis and septic shock reduces hospital mortality","volume":"19","author":"Garnacho-Montero","year":"2015","journal-title":"Crit Care"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1164\/rccm.201609-1848OC","article-title":"The timing of early antibiotics and hospital mortality in sepsis","volume":"196","author":"Liu","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit Care Med"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/17476348.2019.1562339","article-title":"The burden of community-acquired bacterial pneumonia in the era of antibiotic resistance","volume":"13","author":"Peyrani","year":"2018","journal-title":"Expert Rev Respir Med"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12890-019-0944-1","article-title":"Severe community-acquired pneumonia in general medical wards: outcomes and impact of initial antibiotic selection","volume":"19","author":"Wongsurakiat","year":"2019","journal-title":"BMC Pulm Med"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"e4708","DOI":"10.1097\/MD.0000000000004708","article-title":"A cohort study of bacteremic pneumonia: the importance of antibiotic resistance and appropriate initial therapy?","volume":"95","author":"Guillamet","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1471-2334-14-61","article-title":"Clinical implications for patients treated inappropriately for community-acquired pneumonia in the emergency department","volume":"14","author":"Micek","year":"2014","journal-title":"BMC Infect Dis"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"R265","DOI":"10.1186\/cc13095","article-title":"Initial use of one or two antibiotics for critically ill patients with community-acquired pneumonia: impact on survival and bacterial resistance","volume":"17","author":"Adrie","year":"2013","journal-title":"Crit Care"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.chest.2019.04.093","article-title":"Antibiotic use and outcomes after implementation of the drug resistance in pneumonia score in ED patients with community-onset pneumonia","volume":"156","author":"Webb","year":"2019","journal-title":"Chest"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ajic.2016.11.014","article-title":"Prevalence of and outcomes from Staphylococcus aureus pneumonia among hospitalized patients in the United States, 2009-2012","volume":"45","author":"Jacobs","year":"2017","journal-title":"Am J Infect Control"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1001\/archinte.162.19.2229","article-title":"Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus","volume":"162","author":"Blot","year":"2002","journal-title":"Arch Intern Med"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1086\/313440","article-title":"Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms","volume":"29","author":"Gonz\u00e1lez","year":"1999","journal-title":"Clin Infect Dis"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/jamainternmed.2019.7495","article-title":"Empirical anti-MRSA vs standard antibiotic therapy and risk of 30-day mortality in patients hospitalized for pneumonia","volume":"180","author":"Jones","year":"2020","journal-title":"JAMA Intern Med"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"07","DOI":"10.11599\/germs.2013.1030","article-title":"Expected sensitivity to antibiotics in bacterial infections","volume":"3","author":"Streinu-Cercel","year":"2013","journal-title":"Germs"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1016\/j.jinf.2019.11.021","article-title":"Rapid syndromic molecular testing in pneumonia: the current landscape and future potential","volume":"80","author":"Poole","year":"2020","journal-title":"J Infect"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"e0006321","DOI":"10.1128\/AAC.00063-21","article-title":"A pragmatic machine learning approach to predict carbapenem resistance","volume":"65","author":"McGuire","year":"2021","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029159","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T03:04:50Z","timestamp":1746327890000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,20]]},"references-count":28,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000029159","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,20]]},"assertion":[{"value":"2021-06-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}